Bacterial ribosome (protein synthesis machinery)

Bacterial protein synthesis inhibition refers to targeting the **bacterial ribosome**, specifically its unique structural features compared to eukaryotic ribosomes. The bacterial ribosome is a large macromolecular machine composed of two subunits—30S and 50S—that together form the functional 70S particle responsible for translating mRNA into proteins. Many clinically important antibiotics exploit differences between prokaryotic and eukaryotic translation machinery by binding selectively to sites within these subunits. This disrupts various stages of translation—including initiation, elongation, peptide bond formation, translocation along mRNA, or termination—ultimately inhibiting bacterial growth or causing cell death. Because this target is essential for all bacteria but structurally distinct from human cytoplasmic ribosomes, it is a major focus in antibacterial drug development; however, some drugs can also affect mitochondrial protein synthesis due to evolutionary similarities with bacteria[1][2][4]. **Note:** "Bacterial protein synthesis inhibition" describes a process or mechanism rather than a specific molecular entity; therefore it is not itself a canonical target name but refers collectively to components such as "bacterial ribosome" or its functional sites. For structured data purposes use "Bacterial ribosome" as canonical_name. **Is_incorrect:** The provided target name ("Bacterial protein synthesis inhibition") describes an action/mechanism rather than an individual molecule/receptor/complex; thus it should be mapped more specifically as "Bacterial ribosome."

Other names

Bacterial protein synthesis machineryBacterial ribosomal complex70S bacterial ribosome

Inhibition of initiation complex formation on the ribosome[1][3][5]; Blocking aminoacyl-tRNA binding to the A site of the 30S subunit[2][3][6]; Interference with proofreading and codon recognition on the 30S subunit[1][3]; Inhibition of peptidyl transferase activity on the 50S subunit[1][3]